October 17, 2012

Gojo Industries on Wednesday announced the results of a series of independent lab studies testing the ability of instant hand sanitizers to meet Food and Drug Administration Healthcare Personnel Handwash germ kill requirements at various dosage levels.

October 16, 2012

CVS Caremark has announced that it has reached a civil settlement with the United States Department of Justice regarding its investigation into certain business practices of a subsidiary of Longs Drug Stores, which began prior to the acquisition of Longs by CVS Caremark in October 2008.

October 16, 2012

The Federal Trade Commission has voted to approve Watson Pharmaceutical's acquisition of Switzerland-based generic drug maker Actavis.

October 16, 2012

Titled “Fed Up With Phil,” the video is part of campaign to create greater awareness of how pharmacy benefit managers can undermine the relationship between patients and their pharmacists.

October 16, 2012

The number of independents still is down from 2000, and margins of 2.9% represent the lowest in five years.

October 16, 2012

Par Pharmaceutical Cos. has entered into agreements with Watson Pharmaceuticals and Actavis to purchase five generic products currently marketed in the United States by Watson or Actavis, eight abbreviated new drug applications currently awaiting regulatory approval, and a generic product in late-stage development.

October 16, 2012

Perrigo has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application to market over-the-counter omeprazole and sodium bicarbonate capsules in the 20-mg/1,100-mg strength, the store-brand equivalent to Merck's Zegerid OTC.

October 16, 2012

A team of pharmacy students from the University of Arkansas for Medical Sciences College of Pharmacy was named the winner of the 2012 Good Neighbor Pharmacy National Community Pharmacists Association Pruitt-Schutte Student Business Plan Competition, the National Community Pharmacists Association announced Monday.

October 16, 2012

Walgreens pharmacists are on the frontlines of a new transition of care program, WellTransitions, which brings hospitals and health systems together with Walgreens in a coordinated care model designed to reduce readmission rates and overall healthcare costs while improving patient health outcomes and medication adherence, Walgreens announced.

October 15, 2012

The Food and Drug Administration may be willing to speed up trials for drugs that could be a big benefit to society despite their risks.

October 15, 2012

Walmart and Humana have teamed up again to help Medicare beneficiaries afford their prescriptions. With annual enrollment open until Dec. 7, 2012, for 2013 Medicare plans, the Humana-Walmart Preferred Rx Plan announced that it offers one monthly plan premium of $18.50 a month for beneficiaries in all 50 states and Washington, D.C., regardless of where they live.

October 15, 2012

Walgreens will be offering free, personalized Part D plan comparison reports to help beneficiaries identify the plan that best meets their prescription drug needs, the retail pharmacy operator announced Monday.

October 15, 2012

Watson Pharmaceuticals announced that its subsidiary, Watson Laboratories, has received Food and Drug Administration approval on its abbreviated new drug application for irbesartan tablets — the generic equivalent to Sanofi's Avapro — in the 75-mg, 150-mg and 300-mg strengths.

October 12, 2012

Medical supply company BD has introduced a disposable injection pen that it said was designed for drugs requiring frequent, low-volume injections or variable dosing.

October 12, 2012

When given a choice, patients prefer to receive an electronic prescription if they receive a prescription from their physician, according to the most recent Patient Views infographic. To be specific, 64% of respondents said they would choose an e-prescription when provided an option, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. How many patients are actually given a choice as to how they receive their prescription, and how many currently are receiving electronic prescriptions?

October 12, 2012

The Food and Drug Administration has approved an injected drug for lung cancer made by Celgene, the company said Friday.

October 12, 2012

The Food and Drug Administration has approved a new use for a drug made by Roche division Genentech.

October 12, 2012

The Food and Drug Administration has approved a drug made by Sandoz for treating symptoms of various skin diseases.

October 12, 2012

Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software.

October 11, 2012

Frank Scorpiniti, CEO of Rexall Pharma Plus, issued a statement this week applauding the Ontario government’s announcement that it will expand the role of pharmacists to provide more options for Ontarians’ healthcare needs.

October 10, 2012

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

October 10, 2012

Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.

October 10, 2012

With the Medicare Annual Election Period set to begin Oct. 15, Walgreens on Wednesday announced it will be a part of preferred pharmacy networks of four national Medicare Part D plan sponsors: Coventry, Humana, SmartD Rx and UnitedHealthcare.

October 9, 2012

According to Surescripts, almost 400,000 physicians — about 58% of all office-based doctors — were e-prescribing at the end of 2011. The net effect: About 36% of all prescriptions were sent electronically in 2011.